Industry landscapes
Get Pro
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE PARIS EDITION 2026

Paris’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Paris. Find the leaders. Understand the segments. See where the activity is.

Explore in Radar Read the key signals
Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Paris
FR
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
Companies tracked 333Life Sciences ecosystem in Paris Disclosed funding $6.06B155 companies · all recorded rounds Companies hiring 36With open roles at the snapshot Tracked open roles 660 employers posted in the preceding 30 days
MEET THE COMPANIES

Explore Paris’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Explore the full landscape
Life Sciences company highlights in Paris, snapshot 3 September 2026
Company
Owkinowkin.com$355.62M—47$10.66MFYFY2020 filing
Abivaxabivax.com$319.6M—26—
DNA Scriptdnascript.com$309.32M—202$9.04MFYFY2024 filing
Cellectiscellectis.com$267.45M3 roles236—
HiFiBiOhifibio.com$179.5M—75—
Enteromeenterome.com$177.86M—70—
Wandercraftwandercraft.eu$169.86M—117$339.21KFYFY2019 filing
TISSIUMtissium.com$168.73M5 roles107—
ARAGANaragan.fr—4 roles100—
Abbelightabbelight.com—4 roles42—
ArteDroneartedrone.com—4 roles——
Damae Medicaldamaemedical.fr—4 roles37—
CorWavecorwave.com—3 roles77—
Syremissyremis.com—3 roles——
AFYRENafyren.com——32Financial figure available in RadarView in Radar
Affluent Medicalaffluentmedical.com——52$5.05MFYFY2024 filing
AgenTagent-biotech.com——146—
BioSerenitybioserenity.com——340Financial figure available in RadarView in Radar
Bioptimusbioptimus.com————
Bluetensbluetens.com————
Circleswearecircles.com——4—
Curiumcuriumpharma.com——842—
Cuurecuure.com——33—
Nanobiotixnanobiotix.com——102Financial figure available in RadarView in Radar
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only

Explore the live startup set in Radar

No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.

Explore classified startups in Radar ↗
THE KEY SIGNALS

Life Sciences industry KPIs in Paris

A few useful ratios bring the size of this ecosystem into perspective.

3 September 2026
Hiring participation10.8%

36 of 333 tracked companies have open roles.

Funding participation48.9%

163 of 333 tracked companies have a recorded round.

Top 3 funding share16.3%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$4.32M

Midpoint of 382 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 16.3% of disclosed capital, while 51.1% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Paris life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Paris life sciences
$0$270.7M$541.4M$812.1M$1.08B2016: $131.65M20162017: $295.75M20172018: $377.6M20182019: $522.44M20192020: $429.51M20202021: $949.82M20212022: $590.56M20222023: $734.03M20232024: $386.08M20242025: $582.47M2025
View the numbers
Annual life sciences funding and company formation in Paris
YearFunding (USD)FoundedRaising
2016$131.65M2025
2017$295.75M1731
2018$377.6M1733
2019$522.44M2838
2020$429.51M2135
2021$949.82M1728
2022$590.56M937
2023$734.03M737
2024$386.08M619
2025$582.47M122
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Owkin5.9%
  • Abivax5.3%
  • DNA Script5.1%
  • Other companies83.7%

Funding by stage

428 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel72 16.8%
Series A–B115 26.9%
Series C+ / PE22 5.1%
Grants, debt & other219 51.2%

Recent recorded rounds

Latest recorded rounds · USD
7 rounds

Swipe or scroll horizontally to browse.

Unattributed05/2026
Ennov —

Backed by Bregal Sagemount and Ardian.

Seed04/2026
SquareMind $18M

Backed by Sonder Capital and Bpifrance and others.

Grant (prize money)04/2026
AFYREN $3.51M

Backed by Just Transition Fund.

Series B03/2026
Owkin $33M

Backed by OTB Ventures and AIC.

Series B03/2026
May Health $11.7M

Backed by Sofinnova Partners and Trill impact and others.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series D06/2021
HiFiBiOhifibio.com$75M

Backed by Sequoia Capital and Sherpa Healthcare Partners and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
EUR · millions · standalone

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2024 · company accounts; aggregate reporting threshold not met · 2 reporting entities from 7 eligible matches.

Revenue in covered accounts—

Sum of reporting-entity revenue; not Paris market sales.

Net profit / loss—

Combined result for the same cohort.

Aggregate net margin—

Combined net income ÷ combined revenue.

Median company revenue—

The middle covered reporting entity.

Profitable entities—

None of 2 covered entities.

Top-five concentration—

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2024 · 2 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

2 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
PARIS · INDUSTRY COHORTS

How does life sciences compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Paris companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

13 of these companies (3.9%) publish at least one Android app — 24 apps in all, carrying 540.5K installs between them.

AppInstallsRatingStore category
Bluetens Get BetterBluetens321.5K4.3Health & Fitness
REMI - Baby monitor, Sleep TraUrbanHello77.4K1.6Parenting
CuureCuure64.3K—Health & Fitness
LifeazLifeaz38.6K—Education
myFibroScanEchoSens32K—Health & Fitness
AlfinDreem3.3K—Medical
MSF AppParsys1.2K—Medical
iHemostasisDiagnostica Stago1.1K—Medical
CardioskinBioSerenity303—Medical
LP InstallLife Plus241—Business

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q4–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Disease Self Management982.7KREMI - Baby monitor, Sleep Tra 77.4K
Wearable Technology982.5KAlfin 3.3K
Cardiac And Vascular Disorders440KLifeaz 38.6K
Gastroenterology232KmyFibroScan 32K
Sleep Medicine23.6KCardioskin 303
Healthcare It41.7KMSF App 1.2K
Healthcare Booking Platforms31.4KSMUR Connect 233
Hematology21.1KiHemostasis 1.1K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

INSIDE THE INDUSTRY

The Paris life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech254
Medical devices89
Biopharmaceuticals81
Healthtech71
Deep tech69
Enterprise software53
Consumer digital39
Saas17
In vitro diagnostics15
Iot in healthcare15
Immunotherapeutic vaccines12
Consumer internet of things12

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

254companies
11.0%have hiring activity

28 companies hiring · $5.46B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce163
Subscription115
E-commerce - product112
Fee-for-service46
Commission on transaction6
Advertising3
Sponsorship1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Mergers & acquisitionsstago.com ↗

La Caisse and health-care private equity firm Archimed Diagnostics have bought Stago, a French company specialized in the analysis of blood coagulation issues.

Funding roundsmayhealth.com ↗

Healthcare technology startup May Health, led by CEO and co-founder Dr. Robert Auerbach, secured $11.7 million in funding to accelerate development of its innovative treatment technology addressing infertility related to PCOS.

Mergers & acquisitionsbiomemory.com ↗

Biomemory has acquired selected assets from Catalog Technologies, a pioneer in DNA-based data storage and computing systems.

Mergers & acquisitionsabivax.com ↗

In January, French news outlet La Lettre reported that Eli Lilly was pursuing a potential €15 billion ($17.4 billion) Abivax acquisition

IPO activitycellectis.com ↗

Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital Total number of voting rights 02/28/2026 100,590,994 105,825,561

Mergers & acquisitionsartedrone.com ↗

today announces the finalization of the acquisitions of Caranx Medical and Artedrone (the "Acquisitions"), for a closing price paid in Carvolix shares, in order to form a new integrated MedTech named Carvolix,

Funding roundschipiron.co ↗

Paris-based Chipiron secured €14.9 million in a Series A to develop a miniaturised MRI scanner aimed at making magnetic resonance imaging more accessible in clinical settings.

Mergers & acquisitionspathoquest.com ↗

Healthcare specialist private equity fund SHS Capital and its co-investors have agreed to sell PathoQuest SAS, the leader in Next Generation Sequencing (NGS)-based quality control for biopharmaceuticals, to Charles River Laboratories International, Inc.

Funding roundsgensight-biologics.com ↗

today announced the successful completion of a EUR 2,894,715.96 fundraising subscribed by three of its shareholders: Heights Capital, Invus and Alumni Capital

Mergers & acquisitionsaffluentmedical.com ↗

Affluent Medical, based in Paris, has signed binding agreements to acquire Caranx Medical and Artedrone, an operation that will combine three French MedTech companies into a new entity called Carvolix.

Full recorded event mix

Top 10 categories among 235 recorded events in the 24-month window.

Funding rounds
81
Earnings
53
Leadership moves
31
Mergers & acquisitions
20
Company announcements
16
Capital infusions
10
IPO activity
8
Contracts
5
Board Updates
3
Regulatory
3
4 activity cards

Swipe or scroll horizontally to browse.

IPO pipeline

3 companies with recorded IPO activity

Cellectis ↗

IPO · Euronext Growth5 reports

Abivax ↗

OFS · Nasdaq Global Market4 reports

Hybrigenics ↗

IPO · Alternext1 reports

Leadership moves

3 tracked people moves

BioSerenity ↗
Pierre-Yves Frouin

Departure Previously Founder and former CEO of BioSerenity

Okomera ↗
Sidarth Radjou

Departure Previously Chief Executive Officer

Okomera ↗
Silvère Lucquin

Appointment Chief Executive Officer

Contract wins

1 recorded customer wins

Customer: Endotherapeutics Pty LtdMedical device

Regulatory events

5 recorded events

pending approval of draft safeguard planParis Commercial Court

EG 427 ↗

approved for phase Ib/IIa studyU.S. FDA

Abivax ↗

Autorité des Marchés Financiers (AMF)

Nanobiotix ↗

Fast Track designation grantedUnited States Food and Drug Administration

Earnings pulse

Reported company results in the recorded window.

8companies
56period observations
-12.0%median reported growth

Median across 11 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
caisse de depot et placement du quebec→Diagnostica Stago ↗Announced2026-04-29Not stated in snapshot
Biomemory→catalog technologiesAnnounced2026-03-11Not stated in snapshot
eli lilly→Abivax ↗Rumored2026-03-09$17.4B
Carvolix→ArteDrone ↗Completed2026-02-02Not stated in snapshot
charles river laboratories international→PathoQuest ↗Announced2026-01-13Not stated in snapshot
Affluent Medical Medtech→ArteDrone ↗Announced2025-12-29Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

77 postings in the preceding 12 months. The full 232-posting snapshot covers 40 employers.

Expand panel +

Most advertised job titles

Conseiller En Pharmacie H/F39
Marketing Manager15
Attaché De Recherche Clinique/Attachée De Recherche Clinique9
Technicien Mécanique Bureau D\'Étude / Dessinateur Projeteur6
Data Engineer5
Responsable Des Ressources Humaines4
0 internship postings

0 tracked postings mention remote work.

The seniority mix

54 postings specify a level.

unspecified
178
manager
30
senior
16
intern
6
lead
2
THE PEOPLE BUILDING THE FIELD

Founders and leaders

301 founders and chief executives across 206 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

38 profiles with education records.

HEC Paris
14
INSEAD
4
Imperial College London
4
Massachusetts Institute of Technology
3
University College London
2
ESSEC Business School
2
Harvard University
2
University of Cambridge
2

Prior employers

5 profiles with prior-work records.

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

56,523 articles in the measured 12-month window.

Expand panel +
56,523articles in the measured year
13,736articles in 2026Q1
59.6%positive tone in the latest complete year

News volume trends

Life Sciences coverage tagged Paris · articles per complete quarter

010,59521,18931,78442,3792021Q2: 10,6712021Q22021Q3: 11,9522021Q4: 11,5472022Q1: 12,0132022Q2: 12,8542022Q22022Q3: 10,3122022Q4: 14,3842023Q1: 15,8552023Q2: 16,0392023Q22023Q3: 16,0342023Q4: 15,2712024Q1: 21,5152024Q2: 22,3342024Q22024Q3: 36,8512024Q4: 17,8072025Q1: 28,6762025Q2: 17,1922025Q22025Q3: 14,5802025Q4: 13,1702026Q1: 13,7362026Q1
View quarterly article counts
QuarterArticles
2021Q210,671
2021Q311,952
2021Q411,547
2022Q112,013
2022Q212,854
2022Q310,312
2022Q414,384
2023Q115,855
2023Q216,039
2023Q316,034
2023Q415,271
2024Q121,515
2024Q222,334
2024Q336,851
2024Q417,807
2025Q128,676
2025Q217,192
2025Q314,580
2025Q413,170
2026Q113,736

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
18,703 positive · 780 neutral · 17,116 negative
2022
27,562 positive · 1,400 neutral · 20,542 negative
2023
34,105 positive · 1,517 neutral · 27,483 negative
2024
56,615 positive · 2,747 neutral · 38,829 negative
2025
43,809 positive · 1,726 neutral · 27,971 negative

Leading coverage topics

Life Sciences coverage tagged Paris · ranked by full-period article count.

International Political Relations72,763 articles in the full recorded period
19,780 recent · 16,644 prior
International Sports Competitions60,713 articles in the full recorded period
8,564 recent · 17,677 prior
Security And Defense Policies42,362 articles in the full recorded period
12,289 recent · 9,948 prior
Olympic Games Coverage32,395 articles in the full recorded period
4,072 recent · 13,201 prior
International Relations And Diplomacy31,218 articles in the full recorded period
9,066 recent · 7,372 prior
Nationalism And Sovereignty Debates22,274 articles in the full recorded period
4,682 recent · 4,883 prior
Professional League Updates21,057 articles in the full recorded period
3,809 recent · 4,052 prior
Championship Event Highlights19,790 articles in the full recorded period
3,429 recent · 4,723 prior
Government International Agreements Coordination16,931 articles in the full recorded period
4,134 recent · 3,615 prior
Athlete Transfer Rumors15,272 articles in the full recorded period
2,695 recent · 2,565 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

France comparison coverage

KeywordRecentPriorChange
multilateral diplomacy2,1071,26267%
foreign policy analysis2,0231,44440%
national security strategy1,10358788%
conceptual rock albums1,013214724%
international cooperation84054754%
trade dispute mechanisms82451859%
bilateral trade67945749%
nuclear proliferation59231687%
study overseas48427874%
multilateralism47430655%
olympic team selections6993,864-82%
olympic trials5733,557-84%
olympic venues2712,095-87%
summer olympics athletics1091,971-94%
olympians career highlights1551,722-91%

Event and signal lenses

France comparison coverage

All complete annual cohorts shown
Rising

Regulatory Risk

380,445 classified articles

inflation outlook, core inflation rate, inflation breakdown

47.8% critical · 29.4% positive
Rising

Funding Momentum

71,650 classified articles

club valuation, currency intervention policies, inflation reports fx

37.5% critical · 41.7% positive
Rising

Growth

157,603 classified articles

gdp growth rate, gdp acceleration, economic output growth

27.3% critical · 46.3% positive

Life Sciences coverage tagged Paris. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
—India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Challenges in using microbes and plants for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.6
202359.3
202461.9
202567.0
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Issues surrounding microbial hazards, nutritional quality, and health impacts of processed foods.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202270.2
202372.4
202477.4
202599.2
Gene and mRNA Delivery in MedicineCommon problems researchers identify · 03

Gene and mRNA Delivery in Medicine

711 papers

15.8% of this theme group

Barriers to effective gene expression, mRNA therapeutics, and cell‑culture models.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222510.1
20232495.8
20242199.0
20251697.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Limitations in fertiliser use, nutrient uptake, and breeding for resilient, high‑yield crops.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221635.2
20231667.4
20241799.9
20252026.9
Plant Disease and Pest ManagementCommon problems researchers identify · 05

Plant Disease and Pest Management

691 papers

15.3% of this theme group

Complexities of host‑pathogen interactions and integrated strategies for disease control.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.8
202329.2
202427.8
202537.2
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Rising resistance in humans, livestock, and the environment and its broader implications.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Miscellaneous Biological and Chemical TopicsCommon problems researchers identify · 07

Miscellaneous Biological and Chemical Topics

423 papers

9.4% of this theme group

Diverse, less‑cohesive research areas spanning biochemistry to social science aspects.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.4
202321.9
202417.8
202512.5

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative StressCautions · 01

Cellular Toxicity and Oxidative Stress

379 papers

21.5% of this theme group

Potential artefacts and stress responses in in‑vitro and in‑vivo assays.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221034.9
20231110.3
2024911.7
2025818.5
Genomic Selection and Trait PredictionCautions · 02

Genomic Selection and Trait Prediction

257 papers

14.6% of this theme group

Uncertainties in applying genomic tools to plant breeding and animal production.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221437.3
20231478.4
20241637.4
20251817.4
Feed Additives and Nutritional ImpactsCautions · 03

Feed Additives and Nutritional Impacts

245 papers

13.9% of this theme group

Risks and benefits of novel feed compounds for animal health and sustainability.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202222.2
202320.9
202417.3
202518.2
Food Contaminants and Regulatory SafetyCautions · 04

Food Contaminants and Regulatory Safety

240 papers

13.6% of this theme group

Concerns about emerging food additives, contaminants, and their regulatory assessment.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202291.3
202389.1
202495.4
2025105.8
DNA Damage and Repair MechanismsCautions · 05

DNA Damage and Repair Mechanisms

239 papers

13.5% of this theme group

Challenges in interpreting gene‑expression changes linked to genomic instability.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222415.6
20232417.4
20242125.5
20251613.8
Antibiotic Use and Co‑Selection PressuresCautions · 06

Antibiotic Use and Co‑Selection Pressures

206 papers

11.7% of this theme group

Complexities of antibiotic, biocide, and metal interactions driving resistance.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Pesticide Resistance and Biological ControlCautions · 07

Pesticide Resistance and Biological Control

199 papers

11.3% of this theme group

Uncertainties in dose strategies and the efficacy of biocontrol agents.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.9
202365.3
202466.9
202575.8

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging TechniquesOpportunities · 01

Advanced Antibody and Imaging Techniques

1,044 papers

17.4% of this theme group

Innovative fluorescent antibodies and flow cytometry for in‑vivo diagnostics.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022561.4
2023615.1
2024467.1
2025455.3
Gene Modulation for Disease TherapyOpportunities · 02

Gene Modulation for Disease Therapy

1,032 papers

17.2% of this theme group

Promising knockdown and regulation approaches to control apoptosis and cell growth.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022364.0
2023394.7
2024257.4
2025261.8
Functional Plant‑Based FoodsOpportunities · 03

Functional Plant‑Based Foods

878 papers

14.6% of this theme group

Development of antioxidant‑rich ingredients for health‑focused, sustainable diets.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202326.2
202427.1
202545.2
Epigenetic and RNA‑Based DiagnosticsOpportunities · 04

Epigenetic and RNA‑Based Diagnostics

823 papers

13.7% of this theme group

Emerging DNA methylation and messenger‑RNA markers for disease detection.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222397.7
20232377.6
20242114.7
20251613.7
Novel Antimicrobials and PostbioticsOpportunities · 05

Novel Antimicrobials and Postbiotics

809 papers

13.5% of this theme group

Exploration of plant‑derived agents and microbial metabolites to combat resistance.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.4
2024554.5
2025649.8
Genetic Improvement of Crop TraitsOpportunities · 06

Genetic Improvement of Crop Traits

717 papers

11.9% of this theme group

Leveraging germplasm and quantitative trait loci for higher yields and resilience.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202253.0
202345.3
202439.2
202540.8
Sustainable Biomass and Biofuel InnovationsOpportunities · 07

Sustainable Biomass and Biofuel Innovations

697 papers

11.6% of this theme group

Using microbial fermentation and agri‑food by‑products for greener energy and materials.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221514.8
20231566.1
20241742.6
20251980.2

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.5%
Promising30.4%37.2%
Breakthrough14.1%26.1%
Problem-identifying8.3%9.9%
Cautionary3.5%4.7%
Comparative2.4%3.7%
Critical1.0%1.0%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Paris

Published patent filings in the recorded source window.

Expand panel +
104filings 2016–2025
2assignees
48peak annual filings

Filing momentum

0142841552016: 4020162017: 4820172018: 320182020: 1020202024: 220242025: 12025

Who files the most

Université Paris Descartes
145
Université Paris Iv - Sorbonne
5
UNDERSTAND THE LANDSCAPE

Life Sciences in Paris: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

KEEP EXPLORING

Put Paris in context

All landscapes ↗

Company ecosystem snapshot: 3 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon